UBS Group AG Sells 13,766 Shares of Nutex Health Inc. $NUTX

UBS Group AG cut its holdings in shares of Nutex Health Inc. (NASDAQ:NUTX) by 20.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 55,025 shares of the company’s stock after selling 13,766 shares during the period. UBS Group AG owned approximately 0.78% of Nutex Health worth $9,058,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in NUTX. State of Alaska Department of Revenue bought a new position in Nutex Health during the third quarter worth about $30,000. BNP Paribas Financial Markets lifted its holdings in Nutex Health by 966.7% during the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock worth $40,000 after acquiring an additional 290 shares in the last quarter. Bank of America Corp DE lifted its holdings in Nutex Health by 6,590.3% during the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after acquiring an additional 2,043 shares in the last quarter. Vestcor Inc bought a new position in Nutex Health during the third quarter worth about $111,000. Finally, New York State Common Retirement Fund bought a new position in Nutex Health during the second quarter worth about $137,000. 5.32% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms have weighed in on NUTX. Weiss Ratings upgraded Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Wall Street Zen upgraded Nutex Health from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, Nutex Health presently has an average rating of “Moderate Buy” and a consensus target price of $205.00.

Nutex Health Stock Performance

Shares of Nutex Health stock opened at $126.30 on Monday. The firm has a market cap of $868.94 million, a price-to-earnings ratio of 9.76 and a beta of 0.25. The stock’s 50-day moving average is $106.26 and its 200-day moving average is $127.83. Nutex Health Inc. has a one year low of $77.21 and a one year high of $193.07. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.14 and a quick ratio of 3.12.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings results on Thursday, April 30th. The company reported $6.52 EPS for the quarter, beating analysts’ consensus estimates of $3.99 by $2.53. The company had revenue of $216.49 million for the quarter, compared to analyst estimates of $227.80 million. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.